Case 2.: Response in a patient with metastatic adrenal cortical carcinoma with thalidomide

被引：18
作者：
Chacón, R [1 ]
Tossen, G
Loria, FS
Chacón, M
机构：
[1] Alexander Fleming Inst, Dept Med, Buenos Aires, DF, Argentina
[2] Alexander Fleming Inst, Dept Surg Oncol, Buenos Aires, DF, Argentina
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 07期
关键词：
D O I：
10.1200/JCO.2005.03.195
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1579 / 1580
页数：2
相关论文
共 4 条
[1]   Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma [J].
Bonacci, R ;
Gigliotti, A ;
Baudin, E ;
Wion-Barbot, N ;
Emy, P ;
Bonnay, M ;
Cailleux, AF ;
Nakib, I ;
Schlumberger, M .
BRITISH JOURNAL OF CANCER, 1998, 78 (04) :546-549
[2]   THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J].
DAMATO, RJ ;
LOUGHNAN, MS ;
FLYNN, E ;
FOLKMAN, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4082-4085
[3]   OPTIMAL TREATMENT OF ADRENOCORTICAL CARCINOMA WITH MITOTANE - RESULTS IN A CONSECUTIVE SERIES OF 96 PATIENTS [J].
HAAK, HR ;
HERMANS, J ;
VANDEVELDE, CJH ;
LENTJES, EGWM ;
GOSLINGS, BM ;
FLEUREN, GJ ;
KRANS, HMJ .
BRITISH JOURNAL OF CANCER, 1994, 69 (05) :947-951
[4]   THE TREATMENT OF ADRENOCORTICAL CARCINOMA WITH ORTHO,PARA'-DDD - PROGNOSTIC SIMPLICATIONS OF SERUM LEVEL MONITORING [J].
VANSLOOTEN, H ;
MOOLENAAR, AJ ;
VANSETERS, AP ;
SMEENK, D .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (01) :47-53
1